101 related articles for article (PubMed ID: 17270918)
1. The genetic profile of a tumor as a determinant of its response to radiotherapy: a computer simulation of two different radiotherapeutic schemes.
Dionysiou DD; Peristeris T; Stamatakos GS; Nikita KS; Uzunoglu NK
Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3035-8. PubMed ID: 17270918
[TBL] [Abstract][Full Text] [Related]
2. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation.
Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS; Marioli A
J Theor Biol; 2004 Sep; 230(1):1-20. PubMed ID: 15275995
[TBL] [Abstract][Full Text] [Related]
3. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
[TBL] [Abstract][Full Text] [Related]
4. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
Ginsberg T; Ulmer W; Düchting W
Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
[TBL] [Abstract][Full Text] [Related]
5. A computer simulation of in vivo tumour growth and response to radiotherapy: new algorithms and parametric results.
Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS
Comput Biol Med; 2006 May; 36(5):448-64. PubMed ID: 15916755
[TBL] [Abstract][Full Text] [Related]
6. Modeling tumor growth and irradiation response in vitro--a combination of high-performance computing and web-based technologies including VRML visualization.
Stamatakos GS; Zacharaki EI; Makropoulou MI; Mouravliansky NA; Marsh A; Nikita KS; Uzunoglu NK
IEEE Trans Inf Technol Biomed; 2001 Dec; 5(4):279-89. PubMed ID: 11759834
[TBL] [Abstract][Full Text] [Related]
7. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.
Dionysiou DD; Stamatakos GS; Gintides D; Uzunoglu N; Kyriaki K
Open Biomed Eng J; 2008 Sep; 2():43-51. PubMed ID: 19662116
[TBL] [Abstract][Full Text] [Related]
8. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.
Stamatakos GS; Antipas VP; Uzunoglu NK; Dale RG
Br J Radiol; 2006 May; 79(941):389-400. PubMed ID: 16632619
[TBL] [Abstract][Full Text] [Related]
9. A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy.
Stamatakos G; Antipas VP; Ozunoglu NK
Methods Inf Med; 2007; 46(3):367-75. PubMed ID: 17492124
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
11. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme.
Patel V; Hathout L
Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925
[TBL] [Abstract][Full Text] [Related]
12. [Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].
Naydenov E; Tzekov C; Minkin K; Nachev S; Marinov M
Khirurgiia (Sofiia); 2009; (2-3):69-74. PubMed ID: 20506796
[TBL] [Abstract][Full Text] [Related]
13. Computer simulation of clinical irradiation schemes applied to in vitro tumor spheroids.
Düchting W; Lehrig R; Rademacher G; Ulmer W
Strahlenther Onkol; 1989 Dec; 165(12):873-8. PubMed ID: 2603123
[TBL] [Abstract][Full Text] [Related]
14. Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo.
Stamatakos GS; Antipas VP; Uzunoglu NK
Comput Biol Med; 2006 Nov; 36(11):1216-34. PubMed ID: 16207487
[TBL] [Abstract][Full Text] [Related]
15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
16. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
18. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide.
Stamatakos GS; Antipas VP; Uzunoglu NK
IEEE Trans Biomed Eng; 2006 Aug; 53(8):1467-77. PubMed ID: 16916081
[TBL] [Abstract][Full Text] [Related]
19. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
Yang Y; Xing L
Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
